Update on marijuana

Journal of Psychosocial Nursing and Mental Health Services

Volumn 47, Issue 10, 2009, Pages 19-22

  McGulnness, Teena M ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID;

ADOLESCENT; AFFECT; ARTICLE; CANNABIS ADDICTION; CHEMICALLY INDUCED DISORDER; COGNITION; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; HUMAN; LUNG DISEASE; NURSING; NURSING ASSESSMENT; PSYCHOSIS;

ADOLESCENT; AFFECT; CANNABINOIDS; COGNITION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG DISEASES; MARIJUANA ABUSE; NURSING ASSESSMENT; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 74049108613     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20090902-03     Document Type: Article

References (16)

1. Andréasson, S., Allebeck, P., Engström, A., & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483-1486.
2. Budney, A.J., Roffman, R., Stephens, R.S., & Walker, D. (2007). Marijuana dependence and its treatment. Addiction Science & Clinical Practice, 4(1), 4-16.
3. Fergusson, D.M., Poulton, R., Smith, P.F., & Boden, J.M. (2006). Cannabis and psychosis. BMJ, 332, 172-175.
4. Fernandez-Espejo, E., Viveros, M.P., Nunez, L., Ellenbroek, B.A., & Rodriguez de Fonseca, F. (2009). Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology. Advance online publication. doi:10.1007/s00213-009-1612-6
5. Geller, T, Loftis, L., & Brink, D.S. (2004). Cerebellar infarction in adolescent males associated with acute marijuana use. Pediatrics, 113, e365-e37O.
6. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokinetics, 42, 327-360.
7. Grotenhermen, F. (2007). The toxicology of cannabis and cannabis prohibition. Chemistry & Biodiversity, 4, 1744-1769.
8. Johnston, L.D., O'Malley, P.M., Bachman, J.G., & Schulenberg, J.E. (2009). Monitoring the future: National results on adolescent drug use: Overview of key findings, 2008 (NIH Publication No. 09-7401). Retrieved August 12, 2009, from the Monitoring the Future Web site: http://www.monitoringthefuture.org/ pubs/monographs/overview2008.pdf
9. Massi, P., Vaccani, A., & Parolaro, D. (2006). Cannabinoids, immune system and cytokine network. Current Pharmaceutical Design, 12, 3135-3146.
10. Matochik, J.A., Eldreth, D.A., Cadet, J.L., & Bolla, K.I. (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence, 77, 23-30.
11. Neuspiel, D.R. (2007). Marijuana. Pediatrics in Review, 28, 156-157.
12. Reece, A.S. (2009). Chronic toxicology of cannabis. Clinical Toxicology, 47, 517-524.
13. Schweinsburg, A.D., Brown, S.A., & Tapert, S.F. (2008). The influence of marijuana use on neurocognitive functioning in adolescents. Current Drug Abuse Reviews, 1, 99-111.
14. Schweinsburg, A.D., Nagel, B.J., Sch-weinsburg, B.C., Park, A., Theilmann, R.J., & Tapert, S.F. (2008). Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Research, 163, 40-51.
15. Substance Abuse and Mental Health Services Administration. (2007). Results from the 2006 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Retrieved August 12, 2009, from http://www.oas.samhsa.gov/ NSDUH/2K6NSDUH/2K6results.cfm
16. Yiicel, M., Lubman, D.I., Solowij, N., & Brewer, W.J. (2007). Understanding drug addiction: A neuropsychologi-cal perspective. Australian and New Zealand Journal of Psychiatry, 41, 957-968.